570416-35-2

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-6-isopropylpyridazine is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and properties allow it to be a key component in the development of new medications with potential therapeutic benefits.
Used in Agrochemical Industry:
3-Chloro-6-isopropylpyridazine is used as an agrochemical intermediate for the production of pesticides and other crop protection agents. Its biological activity can contribute to the development of effective and environmentally friendly solutions for agricultural challenges.
As a Research Compound:
3-Chloro-6-isopropylpyridazine is used as a research compound in the study of pyridazine chemistry and its potential applications. Its unique structure and properties make it an interesting subject for further research and development, with the aim of discovering new uses and expanding its applications in various fields.

Upstream product

• 570416-36-3 6-isopropylpyridazin-3(2H)-one 

Downstream Products

• 570416-37-4 6-isopropylpyridazin-3-amine 

Relevant academic research and scientific papers

BICYCLIC CGRP RECEPTOR ANTAGONISTS

The present invention is directed to bicyclic compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS

The present invention is directed to heterocyclic compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical composi

BENZAMIDE CGRP RECEPTOR ANTAGONISTS

The present invention is directed to benzamide compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.

FUSED HETEROCYCLIC SULFONYLUREA COMPOUND, HERBICIDE CONTAINING THE SAME, AND METHOD OF CONTROLLING WEED WITH THE SAME

The present invention provides a compound represented by the formula: wherein Q represents a fused heterocyclic group, X and Y are the same or different and each represent an optionally halogenated lower alkyl group, an optionally halogenated lower alkoxy group, etc. , or a salt thereof, as well as a herbicide comprising the compound or a salt thereof, which exhibits a significant effect for control of sulfonylurea herbicide-resistant weeds in paddy fields and can reduce the number of active ingredients in a combined preparation and a method of controlling sulfonylurea herbicide-resistant weeds which comprises using the same.